Tag Archives: ketamine

Ketamine for Depression: Research versus Marketing

This post is a part of our Bioethics in the News series By Arthur Ward, PhD Just weeks ago, the U.S. Food and Drug Administration approved Ketamine as the first new drug in decades for treatment of depression. Or rather, while the … Continue reading

Posted in Bioethics in the News, Uncategorized | Tagged , , , , , , , , , , | 2 Comments